NCT03391869View on ClinicalTrials.gov

Nivolumab and Ipilimumab With or Without Local Consolidation Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer

PHASE3RecruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

December 29, 2017

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Lung AdenocarcinomaLung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8
Interventions
BIOLOGICAL

Ipilimumab

Given IV

PROCEDURE

Local Consolidation Therapy

Undergo radiation and/or surgery

BIOLOGICAL

Nivolumab

Given IV

OTHER

Quality-of-Life Assessment

Ancillary studies

RADIATION

Radiation Therapy

Undergo radiation

PROCEDURE

Therapeutic Conventional Surgery

Undergo surgery

Trial Locations (5)

77030

RECRUITING

M D Anderson Cancer Center, Houston

77079

RECRUITING

MD Anderson West Houston, Houston

77384

RECRUITING

MD Anderson in The Woodlands, Conroe

77478

RECRUITING

MD Anderson in Sugar Land, Sugar Land

77573

RECRUITING

MD Anderson League City, League City

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER